Search the Site

 
News and views

Stay informed

Home / News and views
Back
News > News Article

09 May 2022

Covid update - 6 May

 

Confirmed move to green on 10 May

The College of Optometrists has confirmed that health systems across the UK support moving to the College's 'Green' phase from Tuesday 10 May.

Key messages from the College are:

  • The GOC amber phase easements will not apply from 10 May
  • Cease Covid-19 specific decontamination protocols
  • Cease performing Covid-19 modified eye examinations but continue providing a needs-led examination
  • Physical distancing is no longer a requirement in primary eye care settings in England and Scotland. Changes to physical distancing guidance in NI and Wales are pending
  • You should revert to following the College Guidance for Professional Practice and your nation's IPC guidance for healthcare settings.

The College also reminds the sector that living with Covid will mean some measures continue to apply. These include:

  • Practice staff should continue to wear a fluid-resistant face mask
  • Face coverings should continue to be recommended to service users
  • Following country-specific lateral flow testing guidance.

Read the full College advice


Northern Ireland - Covid testing and isolation guidance

The NI Department of Health has updated guidance on testing and isolation for healthcare providers. From 4 May, staff with symptoms of Covid-19 should take an LFD test instead of a PCR. It also confirms that staff in patient-facing roles should continue to test twice weekly using LFDs. The guidance also explains what to do if you test positive for Covid-19 or have symptoms but test negative. Read the complete guidance

 

Share this page
For more information please contact:
FODO
FODO

Subscribe

* indicates required
I confirm I would like to receive the following newsletter:

Press enquiries

Media enquiries should be directed to [email protected] or call 020 7298 5151.

We are happy to put you in touch with our expert policy advisers who can comment on a variety of issues.

You can also follow us on Twitter and LinkedIn.